Beryl Drugs standalone net profit declines 35.71% in the December 2019 quarter
Sales decline 26.47% to Rs 2.25 crore
Net profit of Beryl Drugs declined 35.71% to Rs 0.09 crore in the quarter ended December 2019 as against Rs 0.14 crore during the previous quarter ended December 2018. Sales declined 26.47% to Rs 2.25 crore in the quarter ended December 2019 as against Rs 3.06 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales2.253.06 -26 OPM %20.4411.11 -PBDT0.400.27 48 PBT0.200.20 0 NP0.090.14 -36Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content